$CBT

Keohane Sean D sold $7.9M of CBT

Keohane Sean D (President and CEO) sold 91,923 shares of CABOT CORP (CBT) at $86.41 ($7.94M total) on 2026-08-07.

Original reporting
SEC EDGAR · Keohane Sean D
Published Aug 11, 2026, 10:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 10:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CBT
Neutral
medium confidence
Mentioned
$CBT
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBTNeutralLow
01

Why it matters

The newest fact is the CEO’s open-market sale size, price, and post-transaction holdings; it may influence short-term sentiment but lacks fundamental catalysts.

02

Market read

Traders may monitor insider activity as a sentiment input, but this filing alone does not provide new operational or financial guidance.

03

What to watch

The filing does not state a 10b5-1 plan, but it also provides no rationale for the sale; without context, interpreting it as bearish is speculative.

Relevance 6/10Novelty 4/10Timing: filed after-hours on 2026-08-11, covering a sale dated 2026-08-07

Background

The article is an SEC Form 4 insider transaction disclosure for Cabot Corp (CBT).

Company-level read

Ticker impact

$CBTNeutralMedium confidence
Context

Cabot Corp CEO Keohane Sean D filed a Form 4 selling 91,923 shares for about $7.94M at $86.4053 per share.

Expected impact

Likely limited near-term impact; any effect is more sentiment-driven than fundamental.

Evidence & confidence

The filing is a primary-source Form 4, but it is an open-market sale with no 10b5-1 plan stated and no accompanying company guidance, deal, or operational update.

Market effects

No clear sector read-through from a single CEO open-market sale disclosure.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity management and may not imply negative outlook, especially if shares were acquired earlier or for diversification.

Key entities

  • Cabot Corp

    Subject of the Form 4 insider transaction disclosure.

  • Keohane Sean D

    President and CEO who sold shares via an open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBTMed

Cabot Details Interim CFO Appointment as CEO Succession Nears

Cabot Corporation (NYSE: CBT) appointed Steve Delahunt as interim CFO effective 1 October 2026. This follows CEO Sean Keohane's retirement and CFO Erica McLaughlin's promotion to president and CEO. The company reported a significant drop in Q3 2026 net income to $6M from $101M year-over-year, while revenue rose to $982M from $923M. CBT shares were at $80.73 as of 15 September, up 3.18% in 24 hours but down 3.39% over 20 days.

$CBTMedAI 8/10

What Cabot (CBT)'s New 2029 Debt Issuance and 2026 Note Redemption Means For Shareholders

Cabot Corporation (CBT) issued $350M in 4.950% senior notes due 2029, using proceeds to redeem $250M in 3.40% notes maturing in September 2026 and for working capital. The company projects $4B revenue and $479.7M earnings by 2029, requiring 3.5% yearly revenue growth. Analysts' views vary on earnings potential, with some estimating $499M by 2029. The refinancing aims to improve financial flexibility but does not alter near-term business challenges, including margin stabilization and Reinforcemen

$CBTMedAI 8/10

Cabot’s New US$350 Million Bond Issue Might Change The Case For Investing In CBT

Cabot Corporation issued US$350 million in senior unsecured notes due 2029, altering its funding mix. The move may impact investor views on balance sheet flexibility, especially as earnings have softened. Q3 2026 results showed US$6 million net income on US$982 million sales, with full-year EPS guidance of US$2.77. The company projects US$4.0 billion revenue and US$479.7 million earnings by 2029.